Yu, Shen
Shen, Yu
VIAF ID: 261981782 (Personal)
Permalink: http://viaf.org/viaf/261981782
Preferred Forms
- 100 1 _ ‡a Shen, Yu
- 100 0 _ ‡a Yu Shen
-
-
- 100 1 _ ‡a Yu, Shen
-
4xx's: Alternate Name Forms (14)
Works
Title | Sources |
---|---|
Adaptive design and estimation in randomized clinical trials with correlated observations. | |
Analysis of the expression of biomarkers in urinary bladder cancer using a tissue microarray. | |
Analyzing left-truncated and right-censored infectious disease cohort data with interval-censored infection onset | |
Are there racial differences in breast cancer treatments and clinical outcomes for women treated at M.D. Anderson Cancer Center? | |
Assessing effects on long-term survival after early termination of randomized trials | |
Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status | |
Buckley-James-type estimator with right-censored and length-biased data. | |
The clinical significance of soluble CD86 levels in patients with acute myeloid leukemia and myelodysplastic syndrome | |
Comparison between pediatric acute myeloid leukemia (AML) and adult AML in VEGF and KDR (VEGF-R2) protein levels | |
Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemia | |
Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy. | |
Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines | |
DCIS and axillary nodal evaluation: compliance with national guidelines. | |
Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast Cancer: A Systematic Review and Network Meta-analysis | |
Empirical likelihood-based confidence intervals for length-biased data | |
Estimation of a parameter and its exact confidence interval following sequential sample size reestimation trials. | |
Evaluation of age and comorbidity as risk factors after laparoscopic urological surgery | |
Evaluation of loss of heterozygosity before and after interferon therapy in patients with hepatitis C virus infection who developed hepatocellular carcinoma during follow up. | |
Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience. | |
First do no harm: population-based study shows non-evidence-based trastuzumab prescription may harm elderly women with breast cancer | |
Guan mao zong xie ding yu Zhongguo jing ji | |
Has racial difference in cause-specific death improved in older patients with late-stage breast cancer? | |
High-dose chemotherapy in high-risk myelodysplastic syndrome: covariate-adjusted comparison of five regimens. | |
High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia | |
Histopathological Features of Non-Neoplastic Breast Parenchyma Do Not Predict BRCA Mutation Status of Patients with Invasive Breast Cancer | |
Impacts of high-speed rail on urban configuration | |
Increased apoptosis in metastatic human colonic adenocarcinomas. | |
Inference of Tamoxifen's Effects on Prevention of Breast Cancer from a Randomized Controlled Trial | |
Kuan mao tsung hsieh ting yü Chung-kuo ching chi, 1993: | |
Likelihood approaches for the invariant density ratio model with biased-sampling data | |
Lun Meiguo zhu yi | |
Marginal analysis of correlated failure time data with informative cluster sizes | |
Maximum Likelihood Estimations and EM Algorithms with Length-biased Data | |
Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience | |
Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center. | |
Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma | |
Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy. | |
Nomogram to predict the benefit of radiation for older patients with breast cancer treated with conservative surgery | |
Nonparametric estimation of asymptomatic duration from a randomized prospective cancer screening trial. | |
Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis | |
OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisal | |
p63 expression defines a lethal subset of muscle-invasive bladder cancers | |
Parametric likelihoods for multiple non-fatal competing risks and death | |
Patterns of treatment for early stage breast cancers at the M. D. Anderson Cancer Center from 1997 to 2004 | |
Permutation tests for comparing marginal survival functions with clustered failure time data. | |
A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results | |
A Phase l Study of a Tumor-targeted Systemic Nanodelivery System, SGT-94, in Genitourinary Cancers | |
Practical Implications of the Publication of Consensus Guidelines by the American Society for Radiation Oncology: Accelerated Partial Breast Irradiation and the National Cancer Data Base | |
Prognostic factors and risk assessment in chronic myelomonocytic leukemia: validation study of the M.D. Anderson Prognostic Scoring System | |
A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, an | |
Prognostic role of detection method and its relationship with tumor biomarkers in breast cancer: the university of Texas M.D. Anderson Cancer Center experience | |
Prognostic significance of monocytosis in patients with myeloproliferative disorders | |
Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer | |
Prostate cancer incidence in U.S. Air Force aviators compared with non-aviators | |
Quantitative analysis of biomarkers defines an optimal biological dose for recombinant human endostatin in primary human tumors | |
Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancer. | |
Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers | |
A renal mass in the setting of a nonrenal malignancy: When is a renal tumor biopsy appropriate? | |
Risk-specific optimal cancer screening schedules: an application to breast cancer early detection | |
Robust modeling in screening studies: estimation of sensitivity and preclinical sojourn time distribution. | |
Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. | |
Self-designing trial combined with classical group sequential monitoring | |
Semiparametric Accelerated Failure Time Model for Length-biased Data with Application to Dementia Study | |
Semiparametric density ratio modeling of survival data from a prevalent cohort | |
A Semiparametric Regression Cure Model for Interval-Censored Data | |
Statin use in primary inflammatory breast cancer: a cohort study. | |
Statistical methods for analyzing right-censored length-biased data under cox model | |
Surveillance for recurrent bladder cancer using a point-of-care proteomic assay | |
Symptomatic local recurrence of prostate carcinoma after radiation therapy | |
Zhongguo gu dai jia ju | |
关贸总协定与中国经济 | |
木样年华 : 中国古代家具 | |
論美國主義 |